Alfuzosin HCl
Catalog No. A10052
Alfuzosin HCl是用于治疗良性前列腺增生（BPH）的α1受体拮抗剂。 它通过放松前列腺和膀胱颈的肌肉来起作用，使其更容易排尿。
| Catalog Num | A10052 |
|---|---|
| M. Wt | 425.9 |
| Formula | C19H27N5O4.HCl |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 81403-68-1 |
| Synonyms | Uroxatral |
| SMILES | CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC.Cl |
Alfuzosin HCl是用于治疗良性前列腺增生（BPH）的α1受体拮抗剂。 它通过放松前列腺和膀胱颈的肌肉来起作用，使其更容易排尿。
| In vitro | DMSO | Warmed: 83 mg/mL (194.87 mM) | |
| Water | 83 mg/mL (194.87 mM) | ||
| Ethanol | 83 mg/mL (194.87 mM) | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 23.48 mL | 117.4 mL | 234.8 mL |
| 0.5 mM | 4.7 mL | 23.48 mL | 46.96 mL |
| 1 mM | 2.35 mL | 11.74 mL | 23.48 mL |
| 5 mM | 0.47 mL | 2.35 mL | 4.7 mL |
*The above data is based on the productmolecular weight 425.9 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.